Adriano Mollica, Sveva Pelliccia, Valeria Famiglini, Azzurra Stefanucci, Giorgia Macedonio, Annalisa Chiavaroli, . . . Romano Silvestri. (2017). Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAdriano Mollica, et al. Exploring the First Rimonabant Analog-opioid Peptide Hybrid Compound, as Bivalent Ligand for CB1 and Opioid Receptors. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationAdriano Mollica, et al. Exploring the First Rimonabant Analog-opioid Peptide Hybrid Compound, as Bivalent Ligand for CB1 and Opioid Receptors. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.